Danske Bank’s Twist Bioscience TWST Stock Holding History

Danske Bank’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-600	Closed	-$27.1K	–	1655
2024 Q3	$27.1K	Buy	+600	New	+$28.5K	﹤0.01%	1300

Other funds holding TWST

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Danske Bank's TWST Position: Q4 2024 in Review

Danske Bank sold out of Twist Bioscience (TWST) in Q4 2024, closing a stake of 600 shares — an estimated $27.1K sold.

Danske Bank first reported a position in TWST in Q3 2024 and held it in 1 quarter. The position peaked at $27.1K in Q3 2024. 246 funds tracked by Wall St. Rank hold TWST as of Q4 2024.

Danske Bank reported no remaining Twist Bioscience position as of Q4 2024 after selling out during the quarter.
Danske Bank sold 600 Twist Bioscience shares in Q4 2024, an estimated $27.1K.
Danske Bank first reported a position in Twist Bioscience in Q3 2024 and held it in 1 quarter.
Danske Bank's Twist Bioscience position peaked at $27.1K in Q3 2024.
246 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2024.

Based on Danske Bank's 13F filing for Q4 2024, filed 18 Mar 2026.